The Analgesic Efficacy of Protocol for Primary Total Knee Arthroplasty (TKA)
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is a perspective, randomized, blinded study with a parallel design and an allocation
ratio of 1 to 1 for the treatment groups to assess the analgesic efficacy of adding the iPACK
(injection between the popliteal artery and the capsule of the knee) in addition to the
adductor canal block (ACB) for Total Knee Arthoplasty patients (TKA).